Taysha Gene Therapies, Inc. financial data

Symbol
TSHA on Nasdaq
Location
Dallas, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 855% % 91%
Debt-to-equity 60% % -49%
Return On Equity -67% % -141%
Return On Assets -42% % -227%
Operating Margin -1619% % -83%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 273,919,373 shares 34%
Common Stock, Shares, Outstanding 273,915,373 shares 34%
Entity Public Float $370,700,000 USD 1119%
Common Stock, Value, Issued $3,000 USD 50%
Weighted Average Number of Shares Outstanding, Basic 353,309,524 shares 32%
Weighted Average Number of Shares Outstanding, Diluted 353,309,524 shares 32%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $6,310,000 USD -36%
Research and Development Expense $76,776,000 USD 21%
General and Administrative Expense $31,664,000 USD 9%
Operating Income (Loss) $102,130,000 USD -16%
Nonoperating Income (Expense) $2,201,000 USD -97%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $99,929,000 USD -339%
Earnings Per Share, Basic 0 USD/shares -197%
Earnings Per Share, Diluted 0 USD/shares -197%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $297,344,000 USD 89%
Other Assets, Current $456,000 USD -1.9%
Assets, Current $299,951,000 USD 86%
Property, Plant and Equipment, Net $6,805,000 USD -11%
Operating Lease, Right-of-Use Asset $7,463,000 USD -14%
Other Assets, Noncurrent $184,000 USD -16%
Assets $316,554,000 USD 76%
Accounts Payable, Current $5,438,000 USD 10%
Employee-related Liabilities, Current $5,347,000 USD 37%
Liabilities, Current $28,631,000 USD -2.4%
Operating Lease, Liability, Noncurrent $16,506,000 USD -7%
Other Liabilities, Noncurrent $1,576,000 USD 16%
Liabilities $97,565,000 USD 6.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,143,000 USD 51%
Retained Earnings (Accumulated Deficit) $683,449,000 USD -17%
Stockholders' Equity Attributable to Parent $218,989,000 USD 147%
Liabilities and Equity $316,554,000 USD 76%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $22,020,000 USD -11%
Net Cash Provided by (Used in) Financing Activities $52,000 USD -136%
Net Cash Provided by (Used in) Investing Activities $371,000 USD -165%
Common Stock, Shares Authorized 700,000,000 shares 75%
Common Stock, Shares, Issued 273,915,373 shares 34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $22,443,000 USD -12%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,294,000 USD -2.6%
Deferred Tax Assets, Valuation Allowance $114,132,000 USD 24%
Deferred Tax Assets, Gross $116,044,000 USD 23%
Operating Lease, Liability $17,751,000 USD -7.5%
Depreciation $1,103,000 USD -13%
Payments to Acquire Property, Plant, and Equipment $140,000 USD -96%
Lessee, Operating Lease, Liability, to be Paid $25,536,000 USD -12%
Property, Plant and Equipment, Gross $11,190,000 USD -2.9%
Operating Lease, Liability, Current $1,245,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,577,000 USD 3.7%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,485,000 USD -15%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7,785,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,673,000 USD 3.7%
Deferred Tax Assets, Operating Loss Carryforwards $57,034,000 USD 20%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,779,000 USD 4%
Operating Lease, Payments $2,742,000 USD 296%
Additional Paid in Capital $903,578,000 USD 34%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $12,985,000 USD 9.5%
Interest Expense $2,240,000 USD -57%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%